Transcription of Toolkit read only - AC Forum
{{id}} {{{paragraph}}}
anticoagulant . Toolkit . Reducing Adverse Drug Events &. Potential Adverse Drug Events with Unfractionated Heparin, Low Molecular Weight Heparins and Warfarin anticoagulant Toolkit . Reducing Adverse Drug Events & Potential Adverse Drug Events with Unfractionated Heparin, Low Molecular Weight Heparins and Warfarin Developed by Purdue University PharmaTAP in collaboration with the Indiana Patient Safety Center (IPSC), Indiana Hospital Association (IHA) and VHA Central. Copyright 2008 Purdue University PharmaTAP. All Rights Reserved. Permission to use, copy, modify, and distribute all or portions of this Toolkit without fee and without written agreement is hereby granted by Purdue University PharmaTAP. Purdue University PharmaTAP, 6640 Intech Blvd., Suite 120, Indianapolis, IN 46278 2012. ii |. Acknowledgements Thank you to the many individuals who have contributed their time, expertise and creativity for the development of this Toolkit . Their generosity has made this Toolkit possible.
Apr 12, 2007 · iii | Anticoagulant Toolkit Thank you to the many individuals who have contributed their time, expertise and creativity for the development of this toolkit.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
PROTOCOLS FOR ANTICOAGULANT AND THROMBOLYTIC, PROTOCOLS FOR ANTICOAGULANT AND THROMBOLYTIC THERAPY, Guide to Coumadin Warfarin Therapy, ANTICOAGULANT, PERI OPERATIVE MANAGEMENT OF PATIENTS, Anticoagulant therapy, Of anticoagulant, Sterile Aqueous Suspension Schering-Plough, Therapy, Acute pulmonary embolism, ANTICOAGULANT, THROMBOLYTIC, and